In most industries, negative media coverage is a reputation problem. In pharmaceuticals, it is simultaneously a reputation problem, a regulatory trigger, a patient safety signal, an investor confidence issue, and a commercial risk — all activated by the same story, at the same time. A critical article about a pharmaceutical company’s product quality, manufacturing practices,...